Stage I EGFR Lung Adenocarcinoma: Phuong's Survivor Story
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage I
- Subtype
- Adenocarcinoma
- Biomarkers
- EGFR alteration
- Sex
- Female
- Treatment
- surgery
- Outcome
- Cancer-Free / NED
Treatment course, step by step
- She had the right upper lobe of her lung removed.
- No chemotherapy was given after surgery.
What happened, in summary
In 2019, Dr. Phuong Ho developed a mild cough and chest tightness that did not improve with inhalers. Chest X-rays and lung function tests were normal, but her symptoms continued. A pulmonologist later ordered a CT scan, which found an almost 2-centimeter mass in the upper part of her right lung. A biopsy showed Stage I lung adenocarcinoma.
Further scans showed that the cancer was localized. After discussing her options with a thoracic surgeon, Phuong chose to have the right upper lobe of her lung removed. Lymph nodes removed during surgery showed no spread. Tumor testing later found an EGFR alteration. Phuong discussed whether additional treatment was needed, but chemotherapy was not recommended and she did not receive it.
Phuong has been cancer-free for 3 years. She continues exercising to improve her lung capacity and is able to work, travel, and spend time with her family. Her experience also led her to advocate for greater awareness of lung cancer among Asian women who have never smoked and for better access to early detection and health education in underserved communities.
Where this story comes from
This is a lay summary of an account first published by AACR. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer